These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34238152)

  • 21. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
    Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y
    PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic risk assessment model for alternative splicing events and splicing factors in malignant pleural mesothelioma.
    Jiang Y; Zhang C; Chen Y; Zhao S; He Y; He J
    Cancer Med; 2023 Feb; 12(4):4895-4906. PubMed ID: 36031798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of a six-gene prognostic model for cervical cancer based on WGCNA combined with LASSO and Cox-PH analysis.
    Li S; Han F; Qi N; Wen L; Li J; Feng C; Wang Q
    World J Surg Oncol; 2021 Sep; 19(1):277. PubMed ID: 34530829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
    Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma.
    Zhang Y; Tang Y; Guo C; Li G
    Aging (Albany NY); 2021 May; 13(9):12865-12895. PubMed ID: 33946043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
    Wu M; Sun Y; Wu J; Liu G
    Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Hub Genes as Biomarkers Correlated with the Proliferation and Prognosis in Lung Cancer: A Weighted Gene Co-Expression Network Analysis.
    Xu X; Xu L; Huang H; Li J; Dong S; Jin L; Ma Z; Li L
    Biomed Res Int; 2020; 2020():3416807. PubMed ID: 32596300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of five hub genes as monitoring biomarkers for breast cancer metastasis in silico.
    Cai Y; Mei J; Xiao Z; Xu B; Jiang X; Zhang Y; Zhu Y
    Hereditas; 2019; 156():20. PubMed ID: 31285741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
    Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Wang Z; Qiu B; Tan F; Xue Q; Gao Y; Gao S; He J
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):821-841. PubMed ID: 32103339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis.
    Cao Y; Zhu W; Chen W; Wu J; Hou G; Li Y
    Dis Markers; 2019; 2019():5451290. PubMed ID: 31093306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.
    Laszlo V; Hoda MA; Garay T; Pirker C; Ghanim B; Klikovits T; Dong YW; Rozsas A; Kenessey I; Szirtes I; Grusch M; Jakopovic M; Samarzija M; Brcic L; Kern I; Rozman A; Popper H; Zöchbauer-Müller S; Heller G; Altenberger C; Ziegler B; Klepetko W; Berger W; Dome B; Hegedus B
    J Pathol; 2015 Oct; 237(2):203-14. PubMed ID: 26011651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-98 is a prognostic factor for asbestos-induced mesothelioma.
    Kim K; Ko Y; Oh H; Ha M; Kang J; Kwon EJ; Kang JW; Kim Y; Heo HJ; Kim G; Kim JW; Kim YH
    J Toxicol Environ Health A; 2020 Feb; 83(3):126-134. PubMed ID: 32114955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and validation of key modules and hub genes associated with the pathological stage of oral squamous cell carcinoma by weighted gene co-expression network analysis.
    Hu X; Sun G; Shi Z; Ni H; Jiang S
    PeerJ; 2020; 8():e8505. PubMed ID: 32117620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a 5‑microRNA signature and hub miRNA‑mRNA interactions associated with pancreatic cancer.
    Ma X; Tao R; Li L; Chen H; Liu Z; Bai J; Shuai X; Wu C; Tao K
    Oncol Rep; 2019 Jan; 41(1):292-300. PubMed ID: 30365134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of UBE2C as hub gene in driving prostate cancer by integrated bioinformatics analysis.
    Wang Y; Wang J; Tang Q; Ren G
    PLoS One; 2021; 16(2):e0247827. PubMed ID: 33630978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of three hub genes related to the prognosis of idiopathic pulmonary fibrosis using bioinformatics analysis.
    Wang E; Wang Y; Zhou S; Xia X; Han R; Fei G; Zeng D; Wang R
    Int J Med Sci; 2022; 19(9):1417-1429. PubMed ID: 36035368
    [No Abstract]   [Full Text] [Related]  

  • 40. Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma.
    Zhou JG; Zhong H; Zhang J; Jin SH; Roudi R; Ma H
    Front Oncol; 2019; 9():78. PubMed ID: 30828567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.